Cargando…

A Promising Future for Stem-Cell-Based Therapies in Muscular Dystrophies—In Vitro and In Vivo Treatments to Boost Cellular Engraftment

Muscular dystrophies (MD) are a group of genetic diseases that lead to skeletal muscle wasting and may affect many organs (multisystem). Unfortunately, no curative therapies are available at present for MD patients, and current treatments mainly address the symptoms. Thus, stem-cell-based therapies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gois Beghini, Daniela, Iwao Horita, Samuel, Monteiro da Fonseca Cardoso, Liana, Anastacio Alves, Luiz, Nagaraju, Kanneboyina, Henriques-Pons, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861917/ https://www.ncbi.nlm.nih.gov/pubmed/31683627 http://dx.doi.org/10.3390/ijms20215433

Ejemplares similares

Induced Pluripotent Stem Cells: Hope in the Treatment of Diseases, including Muscular Dystrophies
por: Gois Beghini, Daniela, et al.
Publicado: (2020)

Mesenchymal Stem Cells in the Treatment of COVID-19, a Promising Future
por: Beghini, Daniela Gois, et al.
Publicado: (2021)

Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration
por: Henriques-Pons, Andrea, et al.
Publicado: (2022)

Domino Hepatocyte Transplantation: A Therapeutic Alternative for the Treatment of Acute Liver Failure
por: Cardoso, Liana Monteiro da Fonseca, et al.
Publicado: (2018)

Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy
por: Ogundele, Michael, et al.
Publicado: (2021)

Magnetic Nanostructures and Stem Cells for Regenerative Medicine, Application in Liver Diseases
por: Barreto da Silva, Tatiane, et al.
Publicado: (2023)

Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B
por: Hogarth, Marshall W., et al.
Publicado: (2019)

Muscular dystrophy in the mdx mouse is a severe myopathy compounded by hypotrophy, hypertrophy and hyperplasia
por: Duddy, William, et al.
Publicado: (2015)

Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy
por: Vila, Maria C, et al.
Publicado: (2017)

Secreted acid sphingomyelinase as a potential gene therapy for limb girdle muscular dystrophy 2B
por: Bittel, Daniel C., et al.
Publicado: (2022)

Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy
por: Dadgar, Sherry, et al.
Publicado: (2014)

Natural Biopolymers as Additional Tools for Cell Microencapsulation Applied to Cellular Therapy
por: Cardoso, Liana Monteiro da Fonseca, et al.
Publicado: (2022)

Considering the Promise of Vamorolone for Treating Duchenne Muscular Dystrophy
por: Grounds, Miranda D., et al.
Publicado: (2023)

Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit
por: Sreetama, Sen Chandra, et al.
Publicado: (2018)

After Experimental Trypanosoma cruzi Infection, Dying Hepatic CD3(+)TCRαβ(+)B220(+) T Lymphocytes Are Rescued from Death by Peripheral T Cells and Become Activated
por: Vacani-Martins, Natalia, et al.
Publicado: (2020)

Skeletal, cardiac, and respiratory muscle function and histopathology in the P448Lneo− mouse model of FKRP-deficient muscular dystrophy
por: Yu, Qing, et al.
Publicado: (2018)

Computer task performance by subjects with Duchenne muscular dystrophy
por: Malheiros, Silvia Regina Pinheiro, et al.
Publicado: (2015)

Loss of calpain3b in Zebrafish, a Model of Limb-Girdle Muscular Dystrophy, Increases Susceptibility to Muscle Defects Due to Elevated Muscle Activity
por: Prykhozhij, Sergey V., et al.
Publicado: (2023)

Animal models applied to acute-on-chronic liver failure: Are new models required to understand the human condition?
por: Gama, Jaciara Fernanda Gomes, et al.
Publicado: (2022)

A new immunodeficient Duchenne muscular dystrophy rat model to evaluate engraftment after human cell transplantation
por: Sato, Masae, et al.
Publicado: (2023)

Promising Perspective to Facioscapulohumeral Muscular Dystrophy Treatment: Nutraceuticals and Phytochemicals
por: Hangül, Ceren, et al.
Publicado: (2021)

Omigapil Treatment Decreases Fibrosis and Improves Respiratory Rate in dy(2J) Mouse Model of Congenital Muscular Dystrophy
por: Yu, Qing, et al.
Publicado: (2013)

Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy
por: He, Ruojie, et al.
Publicado: (2020)

Identification of Muscle-Specific MicroRNAs in Serum of Muscular Dystrophy Animal Models: Promising Novel Blood-Based Markers for Muscular Dystrophy
por: Mizuno, Hideya, et al.
Publicado: (2011)

In the presence of Trypanosoma cruzi antigens, activated peripheral T lymphocytes retained in the liver induce a proinflammatory phenotypic and functional shift in intrahepatic T lymphocyte
por: Meuser‐Batista, Marcelo, et al.
Publicado: (2020)

Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy
por: Willmann, Raffaella, et al.
Publicado: (2017)

Immunological Tolerance in Liver Transplant Recipients: Putative Involvement of Neuroendocrine-Immune Interactions
por: Gama, Jaciara Fernanda Gomes, et al.
Publicado: (2022)

Fat embolism after fractures in Duchenne muscular dystrophy: an underdiagnosed complication? A systematic review
por: Feder, David, et al.
Publicado: (2017)

Treating Duchenne Muscular Dystrophy: The Promise of Stem Cells, Artificial Intelligence, and Multi-Omics
por: Vera, Carlos D., et al.
Publicado: (2022)

Saying NO to muscular dystrophy
por: Dove, Alan W.
Publicado: (2001)

Fatigue in muscular dystrophies
por: Angelini, Corrado, et al.
Publicado: (2012)

Functional and Molecular Effects of Arginine Butyrate and Prednisone on Muscle and Heart in the mdx Mouse Model of Duchenne Muscular Dystrophy
por: Guerron, Alfredo D., et al.
Publicado: (2010)

Cognitive profile of patients with facioscapulohumeral muscular dystrophy
por: dos Santos, Vanessa Brzoskowski, et al.
Publicado: (2021)

Cardiac Dysrhythmias, Cardiomyopathy and Muscular Dystrophy in Patients with Emery-Dreifuss Muscular Dystrophy and Limb-Girdle Muscular Dystrophy Type 1B
por: Hong, Jong-Seo, et al.
Publicado: (2005)

Mechanism of action and therapeutic route for a muscular dystrophy caused by a genetic defect in lipid metabolism
por: Tavasoli, Mahtab, et al.
Publicado: (2022)

Efficient engraftment of pluripotent stem cell-derived myogenic progenitors in a novel immunodeficient mouse model of limb girdle muscular dystrophy 2I
por: Azzag, Karim, et al.
Publicado: (2020)

Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
por: Trifunov, Selena, et al.
Publicado: (2020)

Genetic Patterns of Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network
por: Kang, Peter B., et al.
Publicado: (2023)

Cost of Illness in Patients with Duchenne Muscular Dystrophy in Portugal: The COIDUCH Study
por: Labisa, Pedro, et al.
Publicado: (2021)

Skeletal Muscle Homeostasis in Duchenne Muscular Dystrophy: Modulating Autophagy as a Promising Therapeutic Strategy
por: De Palma, Clara, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b5191pm2m9k1kb1hdjld57i15v